Name | Number of supported studies | Average coverage | |
---|---|---|---|
retinal rod cell | 5 studies | 23% ± 9% | |
macrophage | 3 studies | 16% ± 1% | |
astrocyte | 3 studies | 28% ± 12% |
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
---|---|---|---|---|---|---|
esophagus | 100% | 751.67 | 1445 / 1445 | 100% | 14.65 | 183 / 183 |
lung | 100% | 1099.07 | 578 / 578 | 100% | 10.07 | 1154 / 1155 |
breast | 100% | 935.20 | 459 / 459 | 100% | 11.26 | 1116 / 1118 |
uterus | 100% | 871.44 | 170 / 170 | 100% | 12.67 | 458 / 459 |
brain | 100% | 512.84 | 2631 / 2642 | 100% | 11.04 | 703 / 705 |
bladder | 100% | 874.43 | 21 / 21 | 99% | 9.64 | 500 / 504 |
ovary | 100% | 726.32 | 180 / 180 | 99% | 7.34 | 426 / 430 |
thymus | 100% | 764.82 | 653 / 653 | 99% | 7.65 | 599 / 605 |
intestine | 100% | 790.86 | 966 / 966 | 99% | 10.30 | 520 / 527 |
stomach | 100% | 583.08 | 359 / 359 | 98% | 11.89 | 281 / 286 |
prostate | 100% | 676.83 | 245 / 245 | 97% | 5.22 | 489 / 502 |
kidney | 100% | 849.85 | 89 / 89 | 97% | 6.65 | 873 / 901 |
skin | 100% | 1060.09 | 1807 / 1809 | 97% | 10.31 | 457 / 472 |
pancreas | 98% | 379.06 | 322 / 328 | 98% | 7.95 | 174 / 178 |
adrenal gland | 100% | 583.66 | 257 / 258 | 90% | 4.30 | 206 / 230 |
liver | 100% | 502.36 | 226 / 226 | 78% | 3.76 | 315 / 406 |
adipose | 100% | 1087.93 | 1204 / 1204 | 0% | 0 | 0 / 0 |
lymph node | 0% | 0 | 0 / 0 | 100% | 13.80 | 29 / 29 |
spleen | 100% | 1120.14 | 241 / 241 | 0% | 0 | 0 / 0 |
tonsil | 0% | 0 | 0 / 0 | 100% | 13.38 | 45 / 45 |
ureter | 0% | 0 | 0 / 0 | 100% | 6.24 | 1 / 1 |
blood vessel | 100% | 704.49 | 1334 / 1335 | 0% | 0 | 0 / 0 |
peripheral blood | 98% | 1110.26 | 912 / 929 | 0% | 0 | 0 / 0 |
heart | 95% | 390.97 | 821 / 861 | 0% | 0 | 0 / 0 |
muscle | 93% | 291.64 | 747 / 803 | 0% | 0 | 0 / 0 |
eye | 0% | 0 | 0 / 0 | 75% | 3.35 | 60 / 80 |
abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
GO_0000460 | Biological process | maturation of 5.8S rRNA |
GO_0071044 | Biological process | histone mRNA catabolic process |
GO_0031125 | Biological process | rRNA 3'-end processing |
GO_0031047 | Biological process | regulatory ncRNA-mediated gene silencing |
GO_0000467 | Biological process | exonucleolytic trimming to generate mature 3'-end of 5.8S rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA) |
GO_0005730 | Cellular component | nucleolus |
GO_0071204 | Cellular component | histone pre-mRNA 3'end processing complex |
GO_0005737 | Cellular component | cytoplasm |
GO_0005634 | Cellular component | nucleus |
GO_0043022 | Molecular function | ribosome binding |
GO_0000175 | Molecular function | 3'-5'-RNA exonuclease activity |
GO_0071207 | Molecular function | histone pre-mRNA stem-loop binding |
GO_0008408 | Molecular function | 3'-5' exonuclease activity |
GO_0019843 | Molecular function | rRNA binding |
GO_0005515 | Molecular function | protein binding |
GO_0046872 | Molecular function | metal ion binding |
Gene name | ERI1 |
Protein name | 3'-5' exoribonuclease 1 (EC 3.1.-.-) (3'-5' exonuclease ERI1) (Eri-1 homolog) (Histone mRNA 3'-end-specific exoribonuclease) (Histone mRNA 3'-exonuclease 1) (Protein 3'hExo) (HEXO) Exoribonuclease 1 |
Synonyms | THEX1 3'EXO |
Description | FUNCTION: RNA exonuclease that binds to the 3'-end of histone mRNAs and degrades them, suggesting that it plays an essential role in histone mRNA decay after replication . A 2' and 3'-hydroxyl groups at the last nucleotide of the histone 3'-end is required for efficient degradation of RNA substrates . Also able to degrade the 3'-overhangs of short interfering RNAs (siRNAs) in vitro, suggesting a possible role as regulator of RNA interference (RNAi) . Required for binding the 5'-ACCCA-3' sequence present in stem-loop structure . Able to bind other mRNAs . Required for 5.8S rRNA 3'-end processing (By similarity). Also binds to 5.8s ribosomal RNA (By similarity). Binds with high affinity to the stem-loop structure of replication-dependent histone pre-mRNAs . In vitro, does not have sequence specificity . In vitro, has weak DNA exonuclease activity . In vitro, shows biphasic kinetics such that there is rapid hydrolysis of the last three unpaired RNA nucleotides in the 39 flanking sequence followed by a much slower cleavage through the stem that occurs over a longer incubation period in the order of hours . . |
Accessions | ENST00000250263.8 A0AA34QW13 ENST00000520332.6 ENST00000519292.5 A0AA34QVV0 Q8IV48 E5RJM3 ENST00000521844.1 E5RIV7 ENST00000520684.5 ENST00000518663.2 ENST00000522612.2 A0AA34QVX9 |